Suzanne M de la Monte Selected Research

aspartic acid 2-oxoglutarate-dependent dioxygenase

9/2010	Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility.
5/2009	Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.
5/2009	Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.
1/2007	Prognostic value of humbug gene overexpression in stage II colon cancer.
1/2007	Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss.
12/2006	Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.
5/2006	Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
1/2004	Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
5/2003	Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells.
7/2002	Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne M de la Monte Research Topics

Disease

44	Insulin Resistance 11/2020 - 02/2005
33	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 01/2002
20	Inflammation (Inflammations) 01/2022 - 08/2008
15	Cognitive Dysfunction 01/2019 - 12/2005
14	Fatty Liver 01/2022 - 01/2009
12	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 06/2003
12	Fetal Alcohol Spectrum Disorders 07/2016 - 06/2007
9	Neoplasms (Cancer) 01/2020 - 07/2002
8	Type 2 Diabetes Mellitus (MODY) 01/2012 - 09/2008
7	Alcoholism (Alcohol Abuse) 05/2016 - 09/2008
6	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2022 - 08/2007
6	Neuroinflammatory Diseases 01/2019 - 01/2012
6	Atrophy 12/2017 - 01/2012
6	Obesity 01/2012 - 09/2008
5	Hepatocellular Carcinoma (Hepatoma) 09/2015 - 05/2006
4	Dementia (Dementias) 01/2019 - 01/2002
4	Diabetes Mellitus 01/2018 - 02/2005
4	Metabolic Diseases (Metabolic Disease) 01/2016 - 01/2012
4	Alcoholic Fatty Liver 08/2011 - 01/2009
4	Carcinoma (Carcinomatosis) 05/2009 - 07/2002
3	Gliosis 01/2019 - 03/2006
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2009
3	Hypoxia (Hypoxemia) 12/2016 - 09/2010
3	Muscular Diseases (Myopathy) 01/2012 - 08/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 11/2008
3	Cholangiocarcinoma 01/2007 - 05/2003
2	Long Term Adverse Effects 01/2022 - 01/2016
2	Infections 01/2021 - 02/2003
2	Brain Injuries (Brain Injury) 01/2020 - 07/2019
2	Non-alcoholic Fatty Liver Disease 01/2018 - 04/2012
2	Fibrosis (Cirrhosis) 01/2013 - 01/2010
2	Spontaneous Abortion (Miscarriage) 03/2010 - 01/2007
2	Adenocarcinoma 05/2009 - 07/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2007 - 07/2002
2	Neuroblastoma 12/2006 - 07/2002
1	COVID-19 01/2021
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2019

Drug/Important Bio-Agent (IBA)

55	Insulin (Novolin)FDA Link 01/2022 - 02/2005
25	Ethanol (Ethyl Alcohol)IBA 01/2022 - 06/2007
23	Insulin-Like PeptidesIBA 01/2019 - 02/2005
19	CeramidesIBA 02/2014 - 01/2009
16	LipidsIBA 01/2022 - 01/2009
15	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
14	NitrosaminesIBA 01/2020 - 01/2009
11	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 09/2010 - 07/2002
9	Mixed Function Oxygenases (Monooxygenases)IBA 01/2017 - 08/2006
8	Streptozocin (Streptozotocin)FDA Link 12/2019 - 02/2005
8	CytokinesIBA 01/2018 - 01/2009
8	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2010 - 12/2005
7	Insulin ReceptorIBA 01/2017 - 02/2005
7	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2002
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2005
6	UbiquitinIBA 01/2019 - 06/2003
6	SmokeIBA 07/2016 - 01/2016
5	Amyloid beta-PeptidesIBA 01/2017 - 02/2005
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 01/2010
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2010 - 02/2005
4	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
4	Nicotine FDA Link 01/2016 - 03/2015
4	KetonesIBA 01/2016 - 03/2015
3	thermozymocidin (myriocin)IBA 01/2022 - 10/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2012 - 04/2007
3	Therapeutic UsesIBA 01/2012 - 01/2009
3	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2011 - 02/2005
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 12/2017
2	ApolipoproteinsIBA 11/2020 - 12/2019
2	Jagged-1 ProteinIBA 01/2017 - 09/2010
2	Aspartic Acid (Aspartate)FDA Link 12/2016 - 01/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2016 - 01/2016
2	GhrelinIBA 05/2016 - 11/2014
2	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2016 - 09/2008
2	3-nitrotyrosineIBA 11/2015 - 06/2012
2	Transcription Factors (Transcription Factor)IBA 11/2015 - 09/2010
2	AcetylcholinesteraseIBA 11/2015 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 12/2006
2	Glycogen Synthase KinasesIBA 01/2013 - 03/2006
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2012 - 12/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2012 - 03/2011
2	Triglycerides (Triacylglycerol)IBA 12/2011 - 01/2009
2	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 04/2011 - 01/2010
2	RNA (Ribonucleic Acid)IBA 03/2011 - 01/2007
2	Biological ProductsIBA 01/2011 - 07/2002
2	Glycoproteins (Glycoprotein)IBA 01/2010 - 12/2003
2	Glycogen Synthase Kinase 3 betaIBA 06/2009 - 09/2008
2	Monoclonal AntibodiesIBA 05/2009 - 07/2002
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2009 - 06/2003
2	AD7c-NTPIBA 06/2004 - 01/2002
1	Serine C-PalmitoyltransferaseIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	VaccinesIBA 01/2021
1	AS 8IBA 01/2021
1	Peptides (Polypeptides)IBA 11/2020
1	Nitroso CompoundsIBA 01/2020
1	Insulysin (Insulin-Degrading Enzyme)IBA 12/2019
1	CalcineurinIBA 12/2019
1	LigandsIBA 01/2019

Therapy/Procedure

8	Therapeutics 07/2018 - 01/2009
1	Oral Pathology 01/2020
1	Aftercare (After-Treatment) 07/2018